Skip to main content
BCPC logo

BCPC · Balchem Corp · Financials

Track BCPC — free
Market Cap
$5.36B
Shares
31.78M
Volume · Nov 18 211.1K Avg daily vol (3M) 249.28K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$1.04B +8.8%
FY2025 Revenue FY2009–FY2025
Net Income
$154.85M +20.5%
FY2025 Net Income FY2009–FY2025
Gross Margin
35.74% +0.5pp
FY2025 Gross Margin FY2009–FY2025
Operating Margin
20.18% +1pp
FY2025 Operating Margin FY2009–FY2025
Diluted EPS
$4.75 +20.9%
FY2025 Diluted EPS FY2009–FY2025
Operating Cash Flow
$216.56M +19%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$1.11B $1.04B $953.68M $922.44M $942.36M $799.02M $703.64M $643.71M $643.68M $594.79M $553.2M $552.49M $541.38M $337.17M $310.39M $291.87M $255.07M $219.44M
— — — -$22.61M -$10.27M -$2.46M -$4.44M -$5.96M -$7.61M -$7.53M -$7.26M — — — — — — —
$704.6M $666.53M $617.48M $620.38M $661.91M $555.85M $479.75M $432.34M $439.43M $405.78M $372.34M $384.4M $397.21M $239.75M $220.85M $205.87M $177.03M $152.48M
$404.38M $370.63M $336.21M $302.06M $280.45M $243.17M $223.9M $211.37M $204.25M $189.01M $180.86M $168.1M $144.17M $97.42M $89.54M $86M $78.04M $66.96M
— 35.74% 35.25% 32.75% 29.76% 30.43% 31.82% 32.84% 31.73% 31.78% 32.69% 30.43% 26.63% 28.89% 28.85% 29.47% 30.59% 30.51%
$20.81M $18.51M $16.79M $15.05M $12.19M $13.52M $10.33M $11.38M $11.59M $9.31M $7.33M $5.99M $4.81M $3.62M $3.42M $2.89M $3.19M $3.3M
$71.02M $67.42M $67.59M $53.42M $55.67M $41.74M $43.79M $36.51M $28.34M $28.08M $27.53M $21.9M $21.46M $12.28M $10.41M $10.6M $9.47M $8.65M
— — — — — — — — — — — $2.9M $2.9M — — — — —
$17.31M $16.99M $19.24M $28.04M $27.27M $25.09M $27.81M $25.79M $24.99M $26.78M $29.77M $26.47M $19.47M $3.98M $3.97M $3.97M $3.92M —
$48.82M $45.69M $47.97M $54.94M $51.85M $48.88M $51.28M $45.86M $44.67M $44.38M $46.2M $39.96M $30.52M $10.47M $9.64M $9.29M $8.56M $8.13M
$174.81M $161.31M $153.3M $142.86M $135.27M $115.67M $112.75M $108.81M $97.15M $92.11M $90.02M $74.14M $62.03M $31.82M $29.76M $29.78M $28.27M $26.3M
$229.57M $209.33M $182.91M $159.19M $145.19M $127.5M $111.15M $102.55M $107.1M $96.9M $90.84M $93.96M $82.14M $65.6M $59.78M $56.23M $49.77M $40.66M
— 20.18% 19.18% 17.26% 15.41% 15.96% 15.8% 15.93% 16.64% 16.29% 16.42% 17.01% 15.17% 19.46% 19.26% 19.26% 19.51% 18.53%
$278.4M $255.02M $230.88M $214.13M $197.03M $176.38M $162.43M $148.42M $151.77M $141.28M $137.04M $133.92M $112.67M $76.08M $69.42M $65.52M $58.33M $48.79M
— — — — — — — — — $7.54M $7.27M $6.59M $5.15M $24K $10K $84K $90K $209K
— — — — — — — — — $12K $9000 $9000 $64K $277K $10K $184K $289K $107K
-$9.19M -$10.3M -$16.46M -$21.93M -$11.44M -$2.27M -$4.73M -$6.08M -$8.07M -$8.42M -$7.9M -$6.89M -$5.09M $216K $67K $513K $361K -$57K
$220.38M $199.03M $166.45M $137.26M $133.75M $125.23M $106.42M $96.48M $99.03M $88.49M $82.93M $87.06M $77.05M $65.82M $59.84M $56.74M $50.13M $40.6M
$49.53M $44.19M $37.98M $28.72M $28.38M $29.13M $21.79M $16.81M $20.46M -$1.58M $26.96M $27.34M $24.23M $20.94M $19.84M $17.97M $16.85M $13.82M
$170.85M $154.85M $128.48M $108.54M $105.37M $96.1M $84.62M $79.67M $78.57M $90.07M $55.97M $59.72M $52.83M $44.87M $40.01M $38.77M $33.28M $26.79M
— 14.93% 13.47% 11.77% 11.18% 12.03% 12.03% 12.38% 12.21% 15.14% 10.12% 10.81% 9.76% 13.31% 12.89% 13.28% 13.05% 12.21%
— — — — — — — — $78.57M $90.07M $55.97M $59.72M $52.83M $44.87M $40.01M $38.77M $33.28M $26.79M
$153.67M $220.14M $96.04M $124.39M $103.21M $86.94M $94.36M $77.71M $76.61M $95.28M $54.24M $57.26M $49.98M $45.83M $40.18M $38.38M $32.58M $26.95M
USD/shares $5.36 $4.80 $3.97 $3.38 $3.29 $2.98 $2.63 $2.48 $2.45 $2.83 $1.78 $1.92 $1.74 $1.51 $1.38 $1.36 $1.19 $0.98
USD/shares $5.31 $4.75 $3.93 $3.35 $3.25 $2.94 $2.60 $2.45 $2.42 $2.79 $1.75 $1.89 $1.69 $1.45 $1.32 $1.28 $1.12 $0.93
shares — 32.27M 32.33M 32.11M 32.02M 32.22M 32.18M 32.14M 32.09M 31.84M 31.52M 31.16M 30.38M 29.62M 28.99M 28.57M 27.96M 27.42M
shares — 32.6M 32.72M 32.45M 32.39M 32.67M 32.5M 32.51M 32.45M 32.23M 31.92M 31.64M 31.17M 30.85M 30.35M 30.24M 29.62M 28.87M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $235.06M in buybacks, $222.45M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current finance lease liabilities 2026-09-30 USD 213,000 10-Q filed 2026-10-23
Current operating lease liabilities 2026-09-30 USD 3,762,000 10-Q filed 2026-10-23
Noncurrent finance lease liabilities 2026-09-30 USD 1,384,000 10-Q filed 2026-10-23
Noncurrent line of credit borrowings 2026-09-30 USD 124,000,000 10-Q filed 2026-10-23
Noncurrent operating lease liabilities 2026-09-30 USD 13,085,000 10-Q filed 2026-10-23
Noncurrent other long-term debt 2026-09-30 USD 21,938,000 10-Q filed 2026-10-23
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
4.91×
Peer median 1.66×
EV/EBIT
23.71×
Peer median 21.29×
P/E (TTM)
31.78×
Peer median 27.74×
Price/Sales (TTM)
4.83×
Peer median 1.51×
Price/Book
4.04×
Peer median 1.88×

Peer medians compare against the 35 similar-size Specialty Chemicals companies (of 71 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Human Nutrition and Health $659,387,000 $600,258,000 $550,751,000 $527,131,000 $442,733,000 $400,330,000 $347,433,000 $341,237,000
Animal Nutrition and Health $230,852,000 $214,710,000 $238,326,000 $262,297,000 $226,776,000 $192,191,000 $177,557,000 $175,693,000
Specialty Products $140,976,000 $132,749,000 $125,965,000 $131,438,000 $117,020,000 $103,566,000 $92,257,000 $75,808,000
Industrial Products — — — — — — $26,458,000 $50,941,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
United States $759,448,000 $723,300,000 $689,601,000 $682,238,000 $584,661,000 $516,347,000 $475,033,000 $482,691,000
Non Us $277,713,000 $230,384,000 $232,838,000 $260,120,000 $214,362,000 $187,297,000 $168,672,000 $160,988,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Product Sales $1,035,272,000 $951,947,000 $919,951,000 $939,166,000 $794,518,000 $666,193,000 $609,741,000 $607,879,000
Royalty $1,889,000 $1,737,000 $2,488,000 $3,192,000 $4,505,000 $4,291,000 $4,360,000 $4,487,000
Bill and Hold — — — — — $1,158,000 — $4,612,000
Co-Manufacturing — — — — — $29,063,000 $24,087,000 $24,259,000
Consignment — — — — — — $2,299,000 —

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Human Nutrition and Health $153,906,000 $135,957,000 $102,419,000 $82,125,000 $76,031,000 $61,397,000 $48,429,000
Specialty Products $42,901,000 $39,906,000 $34,579,000 $32,789,000 $30,020,000 $26,801,000 $28,513,000
Animal Nutrition and Health $18,687,000 $14,013,000 $27,576,000 $36,056,000 $26,179,000 $29,979,000 $25,868,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Human Nutrition and Health 23.3% 22.6% 18.6% 15.6% 17.2% 15.3% 13.9%
Animal Nutrition and Health 8.1% 6.5% 11.6% 13.7% 11.5% 15.6% 14.6%
Specialty Products 30.4% 30.1% 27.5% 24.9% 25.7% 25.9% 30.9%
Key facts CIK 9326 CUSIP 057665200 13F (30d) 433 filings 396 filers Visit website